找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Gene and Cellular Immunotherapy for Cancer; Book 2022

[复制链接]
楼主: 麻烦
发表于 2025-3-28 18:07:45 | 显示全部楼层
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside using mouse models beginning in the first half of the twentieth century led to pioneering work carried out by the group led by Steven A. Rosenberg at the Surgery Branch of the National Cancer Institute (NCI) that developed adoptive cellular therapy (ACT) with tumor infiltrating lymphocytes (TIL). N
发表于 2025-3-28 21:15:19 | 显示全部楼层
发表于 2025-3-29 01:05:06 | 显示全部楼层
发表于 2025-3-29 03:48:22 | 显示全部楼层
发表于 2025-3-29 09:41:02 | 显示全部楼层
René Carbonneau,Richard E. Tremblayin patients with hematologic malignancies, leading to the FDA approval of five CAR-T cells for relapsed or refractory B cell malignancies. The components of these CARs (the extracellular antigen-binding domain, hinge and transmembrane region, co-stimulatory domains, and activation domain) were metho
发表于 2025-3-29 11:56:26 | 显示全部楼层
发表于 2025-3-29 17:14:28 | 显示全部楼层
发表于 2025-3-29 21:17:41 | 显示全部楼层
发表于 2025-3-30 02:50:33 | 显示全部楼层
发表于 2025-3-30 06:28:12 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 06:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表